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Background: The purpose of this study was to determine the incidence and seasonal distribution of viral
etiological agents and to compare their clinical manifestations and disease severity, including single and co
infections.
Methods: Multiplex reverse-transcription PCR was performed for the detection of viruses in nasopharyngeal aspirat.
Disease severity was grouped using a categorization index as very mild/mild, and moderate/severe. Clinical and
laboratory characteristics of hospitalized children with viral respiratory tract infection were analyzed.
Results: Viral pathogens were detected in 103/155 (66.5%) of patients. In order of frequency, identified pathogens
were respiratory syncytial virus (32.0%), adenovirus (26.2%), parainfluenza viruses type 1–4 (19.4%), rhinovirus (18.4%),
influenza A and B (12.6%), human metapneumovirus (12.6%), coronavirus (2.9%), and bocavirus (0.9%). Coinfections
were present in 21 samples. Most of the children had very mild (38.8%) and mild disease (37.9%). Severity of illness
was not worse with coinfections. The most common discharge diagnoses were "URTI" with or without LRTI/asthma
(n=58). Most viruses exhibited strong seasonal patterns. Leukocytosis (22.2%) and neutrophilia (36.6%) were most
commonly detected in patients with adenovirus and rhinovirus (p<0.05). Monocytosis was the most remarkable
finding in the patients (n=48, 53.3%), especially in patients with adenovirus (p<0.05).
Conclusions: RSV and RhV were associated with higher severity of illness in hospitalized children. RSV found to
account for half of LRTI hospitalizations. In AdV and FluA and B infections, fever lasted longer than in other viruses.
Coinfections were detected in 21 of the patients. The presence of coinfections was not associated with increased
disease severity.
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Acute respiratory tract infections (RTIs) are the most
commonly encountered diseases for hospitalization, par-
ticularly in infants and young children. These are the
major causes of morbidity and mortality with a world-
wide disease burden estimated at 112 900 000 and 3.5
million deaths, respectively [1]. RTIs are divided into
two categories, as acute lower respiratory tract infections
(LRTIs) and upper respiratory tract infections (URTIs)
according to localization of the infection. LRTIs are* Correspondence: suat.bicer@yeditepe.edu.tr
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reproduction in any medium, provided the ormore harmful than URTIs. URTIs refer to infections of
the nasopharynx, larynx, tonsillae, sinuses, ears, includ-
ing rhinosinusitis, tonsillitis, pharyngitis, laryngitis/
laryngotracheitis and otitis media. LRTI refers to infec-
tions of the trachea, bronchus, and alveolus, including
tracheitis, bronchitis, bronchiolitis, and bronchopneu-
monia. The etiological agents include many bacteria, vi-
ruses and fungi. However, viral agents have a greater
role in causing RTI as they are more commonly ob-
served. In recent years, many viruses causing RTI have
been discovered, including coronaviruses, human meta-
pneumovirus and human bocavirus. Detection of these
viruses relies on the polymerase chain reaction (PCR) in
virology laboratories. As the agents of RTIs, viruses
have constantly been shown to predominate; thisd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Bicer et al. Italian Journal of Pediatrics 2013, 39:22 Page 2 of 10
http://www.ijponline.net/content/39/1/22majority of the viral agents may be related to the in-
creased use of the PCR in the detection of viruses.
Coinfections with more than one viral etiological agent
exist in 4-33% of children [2,3]. The clinical severity of
RTIs which are caused by viruses are viewed differently
among viral agents. Coinfection may or may not be a
risk factor for disease severity [4-6]. Evidence has also
shown that severe viral infections in infancy and early
childhood are related to recurrent wheezing and asthma
in later life [7].
The purpose of current study was to determine the in-
cidence and seasonal patterns of viral etiological agents
and to compare their clinical manifestations and disease
severity, including single and coinfections.Methods
Patients, demographical factors, and clinical
manifestations of acute RTIs
We have prepared a retrospective cohort study of RTIs in
children, requiring hospitalization at a university hospital
in Istanbul, Turkey. Children hospitalized with upper and/
or lower respiratory tract symptoms and/or signs of RTI
between November 2010 and September 2011, were eli-
gible. The inclusion criteria for this study were: 1) children
<9 years of age; 2) hospitalization at the pediatric ward of
the Yeditepe University Hospital, between November 1,
2010 and September 30, 2011; and 3) a diagnosis of acute
RTI, including URTI, acute bronchitis, acute bronchiolitis,
and bronchopneumonia. The diagnosis for each patient
was performed by the attending physicians based on
standard clinical criteria. Bronchiolitis was recognised in
patients <24 months in whom lower respiratory symptoms
of wheezing, tachypnea and signs of respiratory distress
such as nasal flaring, intercostal/subcostal retractions, and
central cyanosis were observed. The diagnosis of broncho-
pneumonia was established on clinical findings which
include fever, tachypnea and respiratory distress where
focal or diffuse crackles or decreased vesicular sounds and
radiographic findings such as infiltration and/or atelec-
tasia, and/or air bronchograms were present. The diagno-
sis of URTI (including laryngotracheitis) was established
on the basis of symptoms such as coryza, cough, earache,
fever, sore throat, headache, and stridor.
Symptoms used for disease severity assesment were
fever (tympanic temperature of ≥38.0°C), dyspnea, tach-
ypnea, tachycardia (defined as heart rate above the 97th
percentile for that age), hypotension (defined as blood
pressure below the 3rd percentile for age), hypoxemia
(defined as oxygen saturation in room air <94%), dehy-
dration, and convulsion. Disease severity was assessed by
using a categorization index which was similar to
categorization of disease (viral RTIs) severity by Bezerra
et al. [8], as follows:1. Disease severity Group I: Very mild and/or mild
disease. Very mild disease was described as the
upper respiratory tract symptoms/signs only,
requiring hospital admission and none or only one
of the clinical symptoms/signs. Mild disease was
described as the lower respiratory symptoms/
signs +/2 upper respiratory tract symptoms/signs,
requiring hospitalization and none or only one of
the clinical symptoms/signs, and/or bronchiolitis
score of 0–3 points.
2. Disease severity Group II: Moderate and severe
disease. Moderate disease was described as the lower
respiratory tract symptoms/signs +/2 upper
respiratory symptoms/signs, requiring
hospitalization and 2 of the clinical symptoms/signs,
and/or the bronchiolitis score of 4–8 points. Severe
disease was described as the lower respiratory
symptoms/signs +/2 upper respiratory symptoms/
signs, needing hospitalization and ≥3 of the clinical
symptoms/signs, and/or the bronchiolitis score of
9–12 points.
Baseline vital signs including fever, oxygen saturation,
respiratory rate, and pulse rate were listed at the time of
assessment in the pediatric emergency department and
daily afterward following admission in all patients. Patients
with at least two symptoms and/or signs of RTI including
fever, cough, nasal congestion, rhinorrhea, nasal flaring,
intercostal/subcostal retractions, and central cyanosis, re-
ceived a posterior nasal swab for virus detection, generally
within five days of symptom onset. A sensitive multiplex
PCR panel was used to demonstrate 14 viral agents during
acute RTIs in the present study.
We assessed medical records of the patients for under-
lying diseases, past medical history, outpatient respira-
tory visits during the month prior to hospitalization,
respiratory hospitalizations throughout the year prior to
hospital admission, and recent respiratory symptoms of
patients and other family members. The discharge diag-
noses were divided into groups as “primarily URTI”
(without LRTI and/or asthmatic attack) and “primarily
LRTI” (with or without URTI and/or asthmatic attack).
Nasopharyngeal aspirate (NPA) and PCR assays for
respiratory pathogens
Fourteen respiratory viruses were included in the panel.
Multiplex PCR was performed to demonstrate adenovi-
rus (AdV), bocavirus (BcV), human coronaviruses (CoV)
Group 1 (229E and NL63) and Group 2 (OC43 and
HKU1), influenza viruses A&B (FluA&B), human me-
tapneumovirus (MPV), parainfluenzaviruses type 1–4
(PIV1–4), respiratory syncytial virus (RSV), rhinovirus
(RhV). We obtained a nasopharyngeal aspirate (NPA)
sample using a sterile feeding tube and injector. NPA
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or sometimes a research assistant on all subjects within
48 hours of admission using a standardised protocol
[8]. Samples were frozen at −20°C and transported on
ice to the Department of Clinical Microbiology and
Virology Laboratory of our university for viral nucleic
acid amplification.Laboratory analysis
Bacterial blood cultures were obtained from 37 patients.
Three to five milliliters of serum was obtained from each
subject for complete blood counts, C-reactive protein
(CRP) and erytrocyte sedimentation rate (ESR) analyses.
CRP was evaluated as normal (<2.8 mg/L), mildly ele-
vated (2.8-15 mg/L), moderately elevated (16–50 mg/L)
and excessively elevated (>50 mg/L) in 91 children. ESR
was evaluated in 60 children.
Cytopenia was determined with decreases in the three
main cell groups which are leukocytes, platelets, and
erythrocytes. Decreases in leukocytes and leukocyte sub-
groups (lymphocytes, granulocytes) were also analyzed
according to age [9].Statistical analysis
The Fisher Exact Test was used to examine the differ-
ences in pathogen prevalence between disease severity
categories I and II and/or different symptoms/signs; by
setting the level of significance at p<0.05 as significant.
Differences in seasonal distribution, demographic and
clinical characteristics between viruses were examined
using chi-square test, setting the level of significance at
p<0.05 as significant. Statistical computations were done
using SPSS 18 statistical package (SPSS Inc., Chicago).
For the purposes of analysis the following viral agents
were grouped together: AdV, BcV, CoV, Flu A&B, PIV
1–4, RSV, and RhV.Table 1 The distribution of viral agents according to age
Total N (%) Mean age (month) Range (month) 0
AdV 27 (26.2) 49.4 11-96
BoV 1 (0.95) 60 60
CoV 3 (2.9) 65 48-96
FluA&B 13 (12.6) 43.9 7-106
MPV 13 (12.6) 30.6 6-60
PIV1-4 20 (19.4) 32.6 1-106
RhV 19 (18.4) 26 7-72
RSV 33 (32) 26.5 3-104
Total 103 (100) 34.9 1-106
*: p<0.05.
There were significant difference for AdV between the the first group (0–12 monthsResults
Demographical characteristics
One hundred-three patients under nine years of age hos-
pitalized at the Pediatrics Department were enrolled.
There were 61 males and 42 females with a male/female
ratio of 1.4 to 1. The characteristics of patients are
shown in Table 1. The mean age of patients was 34.9
(1–106) months, where 89.4% of patients where 5 years
of age. Among the patients 18.4% were <12 months; 32%
were 13–24 months of age, 39% were 25–60 months,
and 10.6% were 61–106 months (Table 1). There were
no statistically significant differences among age groups.
Among the patients, 42 had other significant comor-
bidities (e.g. chronic bronchitis, other chronic diseases
and prematurity). Thirty-four patients (33%) were at-
tending school and daycare centers.
PCR results
Viral respiratory pathogens were detected in 103/155
(66.5%) NPAs. The distribution of viral etiologic agents
according to age is shown in Table 1. The detected path-
ogens were RSV (32%), AdV (26.2%), PIV 1–4 (19.4%),
RhV (18.4%), Flu (12.6%), MPV (12.6%), CoV (2.9%), and
BcV (0.9%), respectively. RSV was identified more than
any other virus (33/103, p<0.01). Only three CoV and
one BcV infections were detected. AdV was also de-
tected frequently (26.2% of RTIs). Parainfluenza viruses
were detected in 19.4% of patients with PIV3 mani-
festing the major part of PIV (10.6%). Influenza viruses
were found in 12.6% of samples with Flu A being the
most common (8.7%). The most common pathogens in
single infections (n=82; 79.6% total samples) were RSV
(28%) and AdV (24.4%) with CoV and BcV comprising a
much smaller percentage (2.4% and 1.2% respectively)
(Table 2). Coinfection with two or more pathogens were
present in 21 samples (20.6%). Two pathogens were
detected in 17 samples (16.5%), three pathogens in three
samples (2.9%), and four pathogens were found in one-12 months 13-24 months 25-60 months 61-106 months
1 5 15* 6*
0 0 1 0
0 0 2 1
2 2 7 2
3 3 7 0
4 6 9 1
3 11 4 1
9 13 9 2
20 32 40 11
) with 3rd (25–60 months) and 4rd (61–106 months) groups.
Table 2 The distribution of viral etiologic agents and coinfections
Total (n) % Single infection % in all single infections Coinfection % in all coinfections
AdV 27 26.2 20 24.5 7 33.3
BoV 1 0.9 1 1.2 0 0
CoV 3 2.9 2 2.4 1 4.7
FluA&B 13 12.6 8 9.7 5 23.8
MPV 13 12.6 7 8.5 6 28.6
PIV1-4 20 19.4 12 14.7 8 38.0
RhV 19 18.5 9 11 10 47.6
RSV 33* 32.0 23 28 10 47.6
Total 103 82 21
*: p<0.05.
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Flu A, who was hospitalized for URTI). The most com-
mon pathogens in coinfected samples were RSV (47.6%),
RhV (47.6%), PIV (38%), AdV (33.3%), MPV (28.6%), Flu
A&B (23.8%), and CoV (4.7%) where the most frequently
detected coinfections were RSV/PIV (28.3% of coinfec-
tions) and RhV/AdV (19%) (Table 2).
Patients positive for BcV and CoV were significantly
older (mean 60 and 65 months, respectively) than other
hospitalized patients (mean 33.7 months). Patients posi-
tive for RhV and RSV were significantly younger (mean
26 and 26.5 months, respectively) than other hospital-
ized patients (mean 42.6 months) (p<0.05); although pa-
tients with MPV and PIV had similar mean age (30.6
and 32.6 months, respectively) (Table 1).
Clinical manifestations and clinical diagnoses associated
with viruses
Patients were classified under the three major clinical
presentation groups (URTI only, URTI + LRTI, and LRTI
only). Bronchopneumonia and URTI comprised theTable 3 The distribution of clinical diagnoses
n % URTI only URTI + LRTI
AdV 27 26.2 22† 5
BoV 1 0 0
CoV 3 2 1
FluA&B 13 12.6 6 2
MPV 13 12.6 3 3
PIV1-4 20 19.4 7 6
RhV 19 18.5 10 3
RSV 33 32.0 6 5
Coinfection 21 20.4 11 7
Single 82 79.6 30 10
TOTAL 103 41 17
*: These patients are subgroups of LRTI. †: P<0.05.
The discharge diagnoses of patients were divided as “URTI only” (39.8%), URTI + LR
discharge diagnoses were bronchiolitis (15.5%), bronchopneumonia (36%) and asthmajority of discharge diagnoses. Overall, 58 had symptoms
of URTI (56.3%) and 62 had symptoms of LRTI (60.2%),
and 17 of these had symptoms of URTI and LRTI (16.5%).
The discharge diagnoses of patients were divided as “URTI
only” (39.8%), URTI + LRTI (16.5%), and “LRTI only”
(43.7%). Among LRTI and URTI + LRTI patients, the
discharge diagnoses were bronchiolitis (15.5%), broncho-
pneumonia (36%) and asthmatic attack (8.7%). Three of
the children were hospitalized in the intensive care unit
and one intubated. The distribution of discharge diagnoses
are shown in Table 3.
Some viruses were more commonly identified with
symptoms of URTI or LRTI (Table 3). Especially AdV
infection was more commonly associated with URTI
than LRTI (URTI: 81.5%, LRTI: 8.5%) (53.6% of cases of
URTI vs. 8% of cases of LRTI; p=0.000) and RSV was
more largely associated with LRTI (81.8%) than URTI
(18.2%) (43.5% of LRTIs vs. 14.6% of URTIs; p=0.000).
The number of patients in whom coinfection was found,
was not different statistically in two major clinical mani-
festation groups (26.8% of URTIs; 16.1% of LRTIs).LRTI only Bronchiolitis* Pneumonia* Asthma*
0 1 4 0
1 0 1 0
0 0 0 1
5 1 4 2
7 2 7 1
7 1 11 1
6 1 6 2
22† 10 14 3
3 0 9 1
42 16 28 8
45 16 (15.5%) 37 (36%) 9 (8.7%)
TI (16.5%), and “LRTI only” (43.7%). Among LRTI and URTI + LRTI patients, the
matic attack (8.7%).
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Patients were divided into two groups according to level
of clinical severity; 76.7% (n=79) of the patients were to
be in the “disease severity Group I”, and 23.3% (n=24) of
the patients were to be in the “disease severity Group
II”. Patients who were in Group I have very mild (38.8%)
and mild disease (37.9%), however, patients who were in
Group II have moderate (14.6%) and severe (8.7%) dis-
ease. All of the patients with AdV were in Group I, they
have mostly very mild disease than mild disease (81.5%
vs. 18.5%, respectively), none of them had moderate and
severe disease (p=0.000). Most of the patients with coin-
fection had very mild (47.6% of coinfections) and mild
disease (38.0% of coinfections). Severity of illness was
not worse with coinfections (Table 4).
RSV was the second virus that caused hospitalization
of young children. Patients positive for RSV (mean 26.5
months, 0–24 months: 66.7%) were significantly younger
than the other hospitalized patients except for RhV
(mean 26.0 months, 0–24 months: 73.7%). HospitalizedTable 4 Correlation between disease severity and
symptoms, laboratory/lung radiography results,
hospitalization time, diagnosis groups
Symptoms & laboratory &
lung radiography results
& hospitalization time &
diagnosis groups
Disease severity
Group I Group II P
AdV 27 (34.2%) 0 0.000
Flu A & B 11 (14%) 2 (8.3%) NS
MPV 10 (12.6%) 3 (12.5%) NS
PIV1-4 16 (20.2%) 4 (16.7%) NS
RhV 12 (15.2%) 7 (29.2%) NS
RSV 22 (27.8%) 11 (45.9%) NS
Coinfection 18 (22.8%) 3 (12.5%) NS
Single infection 61 (77.2%) 21 (87.5%) NS
Leukocytosis 15 (19%) 5 (20.8%) NS
Leukopenia 5 (6.3%) 0 NS
Positive lung radiography 20 (25.3%) 14 (58.4%) NS
Hospitalization <48 hours 17 (21.5%) 0 0.01
Hospitalization 48–72 hours 29 (36.7%) 6 (25%) NS
Hospitalization 73–96 hours 17 (21.5%) 4 (16.7%) NS
Hospitalization 97–120 hours 8 (10.1%) 3 (12.5%) NS
Hospitalization >120 hours 6 (7.6%) 11 (45.9%) 0.000
Hospitalization >96 hours 20 (25.2%) 15 (62.5%) 0.001
Primarily URTI 41 (51.9%) 0 0.000
Primarily LRTI 38 (48.1%) 24 (100%) 0.000
Bronchiolitis 11 (14%) 5 (20.8%) NS
Bronchopneumonia 25 (31.6%) 12 (50%) NS
Asthmatic attack 2 (2.5%) 7 (29.2%) 0.000
NS: Nonsignificant.children with RSV had relatively a long hospitalization
duration (>96 hours, 37.1%) compared to patients with
other respiratory viruses.
Patients infected with RSV, MPV, and PIV1-4 were com-
monly diagnosed as LRTI (p<0.05), however, a higher per-
centage of AdV positive patients were diagnosed as URTI
(p=0.000) in comparison to other viruses. Symptoms of
hospitalized children were fever (50.5%), dyspnea (26.2%),
tachypnea (24.2%), dehydration (12.6%), hypoxia (4.8%),
hypotension (2.9%), and convulsion (3.8%). Clinical char-
acteristics associated with viral pathogens are shown in
Table 5 which displays clinical characteristics of single
viral infections.
Fever was observed in 50.5% of the patients with RTIs,
and its duration was between 72–150 hours. This symp-
tom was observed in 92.6% with AdV. Moreover, pa-
tients with single AdV infections were more likely to
have fever than viral RTIs without AdV (p=0.000). AdV
and influenza A&B had the longest mean duration of
fever in RTI cases, 111.1 hours and 150 hours, respect-
ively. The mean duration of fever in single viral infec-
tions was prolonged in patients with AdV (5.1 days).
The rate of dyspnea in RTIs with single RSV infections
was 92.6% (43.5% of dyspneic patients). Dyspnea was
more likely to be detected with single RSV infections
(43.5% of dyspneic patients).
Seasonal distribution
The seasonal distribution of viruses is displayed in
Figure 1. Most viruses exhibited strong seasonal pat-
terns. Some viruses were most frequently detected in the
cold and rainy season. The clear seasonal patterns of in-
fluenza A&B and CoV (winter/spring), RSV (fall/winter/
spring) and MPV (spring) somewhat overlapped in terms
of incidence. Influenza A was identified during January
through May with a peak occurrence in April. Influenza
B was observed in January/March/May. BcV and some
cases of ADV were determined in the warm months.
PIV and RhV did not have a clear seasonal pattern. RhV
was detected throughout the study months, although
its percentage rose in the spring (March and April),
and decreased between December-March. Different PIVs
(PIV1-4) were identified in different months during the
year the study was conducted. PIV1 was identified in
March and June, PIV2 in February and May, PIV4 in
June and August, while PIV3 predominated during
March, and continued through May with a peak in
December. CoV and BcV were detected in low percent-
ages during the study period.
Laboratory results
White blood cell counts were available for 90 (87.4%) of
the patients. Leukocytosis was detected in 20 (22.2%)
patients. Especially AdV (n=10) and RhV (n=6) were
Table 5 Distribution of severe symptoms among single infections
Single infections AdV FluA&B MPV PIV1-4 RhV RSV Total
Fever >38.5°C 18* (90% in single AdV) 5 2 4 2 9 41
Dyspnea 0* 2* 3 3 4 10 (43.5% in single RSV) 23
Tachypnea 1* 1 3 3 4* 8 21
Hypoxia 0 1 0 1 2 1 4
Dehydration 3 1 1 2 2 2 11
Hypotension 0 1 0 0 0 1 2
Convulsion 1 0 0 0 1 0 2
Total 20 8 7 12 9 23 82
*: p<0.05.
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Neutrophilia was detected in 33 patients (36.6%), es-
pecially with AdV (n=15, p=0.000) and RhV (n=9,
p=0.013). Monocytosis was the most significant finding
in the patients (n=48, 53.3%) (p<0.05). Nearly all of the
viruses were associated with monocytosis, especially in
the AdV (n=16, p<0.05) patients. Neutropenia was
detected in 10 patients, especially in those with RSV
(n=4) and PIV (n=4). Lymphopenia was detected in 19
patients which was significant between 2 and 8 years of
ages (p<0.05). Nearly all of the viruses were associated
with lymphopenia; however, this was not a statistically
significant difference among viruses. During the 4-week
follow-up period, white blood cell counts returned to
normal together with the improvement of clinical symp-
toms. None of the patients had permanent cytopenia.
The differences in haematological alterations between
the single and coinfection groups were statistically not
significant.
CRP and ESR were detected in 91 (88.3%) and 60
(58.2%) patients, respectively. High CRP values were the
most remarkable finding in the patients. CRP values
were found to be mildly (n=21), moderately (n=29) and
excessively (n=21) elevated in 71 patients; however, it
was not elevated in 21 patients. ESR was elevated in 44
patients; however, it was not elevated in 16 patients.Figure 1 The seasonal distribution of respiratory viral agents.Blood culture was studied in 37 (35.9%) of the patients.
None of them had positive blood cultures.
Discussion
The gold standard for diagnosing respiratory viruses is a
viral culture of nasopharyngeal samples and/or throat
samples. However, the process may require 3–7 days,
which is a long duration for diagnosis. Although viral
culture is the “golden standard” of diagnosing virus
infection, it limits the sensitivity of the diagnosis, as con-
ventional viral culture has a low sensitivity in compari-
son to RT-PCR. Nucleic acid PCR types of laboratory
tests with short durations (of less than 24 hours) have
become available and with high sensitivity. This study
clearly demonstrates the clinical manifestations, clini-
cal severities and seasonal patterns of respiratory viral
agents of URTI and LRTI in Turkish children. Further-
more, it provides new information on the epidemiology
of viral agents in children by assessing the significance
of RSV, MPV, RhV, AdV, and the newly identified viruses
(PIV4, CoV, BcV). Viruses were detected in 66.5% of the
hospitalized patients. This detection rate was similar
to those found in other studies of hospitalized patients
(35-90%) [3,10-12].
Coinfections were common, occurring in 20.4% of RTIs,
with some pathogens, such as RhV and MPV, being com-
monly identified as coinfections while others, such as AdV
and RSV were mostly detected as single infections. Similar
rates (between 11.1% and 39.6%) were found in other PCR
based studies [10,11,13,14]. Sensitive RT-PCR assays make
it possible to identify a large spectrum of viral agents, but
an identified virus may be concerned with persistence of
a virus after a recently afflicted RTI. RhV and BcV may
persist in the upper airways for a long duration. Up to two
months of persistence has been shown in nasopharynx
[14-17]. AdV shedding with the faeces may persist for a
long time after an acute infection [18]; however, extended
shedding of AdV in the nasopharynx was not docu-
mented. For this reason, this persistence also may not
occur in the nasopharynx. However, identification of two
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shedding or asymptomatic persistence of viruses and fur-
ther work would be needed to clarify this situation. Identi-
fication of the viral genome quantitively may be helpful in
explaining coinfections.
Evidence pertaining to the severity of coinfections
compared to single viral infections is conflicting. In our
study, coinfections were not more severe than single in-
fections. The presence of coinfections was not associated
with extended duration of fever. The severity of coinfec-
tion may depend on the viruses involved. In contrast
with some previous studies [4,19,20], coinfections were
not more severe than single infections in this study.
Other studies conducted do support this finding [5,6].
This may have resulted due to smaller numbers of pa-
tients in the moderate and severe categories.
Very few studies have included the full spectrum of
disease severity from mild to life threatening severity. In
this study, over 75% of the patients had a mild or mod-
erate disease. Most viruses were detected in all disease
severity groups. However, patients with RSV and RhV
had moderate and severe disease symptoms more fre-
quently and patients with AdV, CoV and BcV were did
not. These viruses were not the cause of moderate and
severe symptoms in our patients. RSV, RhV and MPV
were also more likely to be detected in patients with
bronchiolitis and bronchopneumonia, confirming and
highlighting the importance of these pathogens.
Our study has estimated the incidence of respiratory
viruses among the hospitalized children with the diag-
nosis of RTI that may be considered as viral etiology. It
has also demonstrated the importance of RSV and AdV
among LRTIs and URTIs, respectively. RSV was the
most significant viral agent associated with pediatric
hospitalizations for LRTI (32%), especially in patients
under two years of age, similar to findings in other
studies (12–60%) [6,12,17]. It was detected in a larger
proportion (35.5%) of hospitalized young (<24 months)
patients. RSV was identified in 43.5% of patients with
pneumonia. RSV is the second virus that results in a
longer hospitalization duration (>96 hours; 37.1%) in
young children (<24 months) compared to other vi-
ruses. It was especially evident in young children that,
RSV was the most frequently detected virus in this
group. Similar to other studies, RSV was associated
with higher severity of diseases. Fever (36.3%), dyspnea
(36.3%) and tachypnea (30.3%) were the most com-
monly encountered symptoms in hospitalized children
with RSV. It was detected during November through
July with peaks in December and May. In 47.6% of
coinfected patients, RSV was identified together RhV,
AdV, PIV, FluA&B and MPV.
PIV is the second most common virus in our study
that associated with LRTI hospitalization (21% of LRTI).It was detected in a larger proportion of hospitalized pa-
tients with RTI (19.4%) than in other similar LRTI stud-
ies (range 0.4–9%) [6,17,20]. This finding was consistent
with 1990–2004 United States National Respiratory and
Enteric Virus Surveillance System data showing PIVs
second only to RSV detected in patients <5 years of age
with RTIs [21]. Singleton et al. detected PIV as a cause
of LRTI in hospitalized children with respiratory diseases
(18%) [12]. In our study, PIV3 caused a greater percent-
age (55%) of PIV infections. PIV was detected in a
smaller percentage (16.1%) of hospitalized young chil-
dren (<24 months) compared to RhV and RSV. Severity
of infection in hospitalized children with PIV was mild
and moderate in general compared to other viruses.
Mean duration of fever is 111.6 hours in hospitalized
children with PIV; this is relatively longer compared to
other viruses except for influenza (150 hours). PIV is the
third virus that results in a long hospitalization duration
(>96 hours; 20%) after RSV and RhV. PIV1-4 were iden-
tified across all the studied months with peak the rate
during early and late spring and early summer. PIV1-4
was detected with other viruses in 38% of the coinfected
patients, especially with RSV.
RhV was the second most common agent identified in
hospitalized children in our study. RhV is one of the in-
creasingly identified viral agents with the use of PCR
[22,23]. It is the most common cause of URTI (especially
common cold) in both adults and children. RhV may
also be associated with LRTI [24], and was detected in
14-24% of hospitalized children with LRTI [25,26]. RhV
may now be considered a major cause of LRTIs in in-
fants [27] and of asthma-triggering in children [28,29]
and adults [30]. The role of RhV in asthma exacerbations
was documented by Johnston et al.; it accounted for 65%
of virus-induced asthmatic attacks [28]. Studies in recent
years [14,31] have shown higher rates of viruses in chil-
dren hospitalized for asthmatic attacks; however, studies
in the later years [32] have shown lower rates (19% to
42%) compared to recent studies. The more extensive
use of PCR for virus identification in recent years may
be responsible for the higher rates in recent studies.
RhV has been identified as the single virus in some
LRTIs [19,30], however, in this study more than half
(52.6%) of the patients with RhV was identified in
coinfections. This was not correlated with other studies.
Hospitalized children with RhV were usually encoun-
tered during summer months [19,30]. The seasonal pat-
tern of RhV in this study correlates with these studies;
RhV was mostly encountered in spring and summer
with a peak incidence occurring in March and April.
The disease severity of patients with RhV was relatively
higher compared to other viruses. Patients with RhV
were 29.2% with moderate to severe symptoms. In chil-
dren with RhV, tachypnea (42.1%), dyspnea (36.8%),
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at levels of severity similar to those observed in children
with RSV. RhV causes the second longest hospitalization
duration (>96 hours; 25.7%), which is especially evident
in young children (<24 months; 35%). RhV was identi-
fied with AdV, RSV, PIV, MPV and CoV in 47.6% of
coinfected patients.
MPV is one of the causes of upper and lower RTIs,
which is a well-recognized viral agent of pneumonia in
preschool and older children, but not a frequently identi-
fied agent in children younger than the former two groups
[3,33]. In contrast to some studies, MPV was mostly
detected in young (<24 months) hospitalized children in
our study. MPV was detected in a higher percentage
(12.4%) of hospitalized children than in other studies (3–
5%) [6,17] except for one study in Alaska (15%) [12]. MPV
infection was associated with URTI and especially LRTI
(77%) in hospitalized children. In contrast to Singleton
et al. [12], MPV infection was associated with mild sever-
ity of disease in our study, but patients, especially young
children, have a relatively long hospitalization time (>96
hours; 25%), compared to children with other viruses ex-
cept RSV and RhV. MPV was identified during spring and
summer with a peak in May. MPV was detected with
other viruses in 28.6% of coinfected patients, especially
with FluA&B, RSV and RhV.
FluA&B was detected in a relatively small percentage
(12.6%) during winter and spring in our study. However,
this percentage was higher than the ones reported in
other studies (0.8–8%) [6,12,17,20]. FluA&B was identi-
fied during January through May with a peak in April.
Seasonal patterns of FluA&B, CoV, RSV and MPV over-
lapped. Patients with FluA&B were older than patients
who were diagnosed with bronchiolitis caused by other
viruses. FluA&B infection was associated with LRTI
(53.8%) and moderate disease severity in patients. Fever
(53.8%) and dyspnea (30.8%) were the most commonly
encountered symptoms in hospitalized children with
FluA&B. Mean duration of fever for this virus is longer
than other viruses (150 hours) in hospitalized children
with FluA&B. In patients with H1N1 influenza A, fever
was reporded in 94.6% of patients with a mean level of
38.6°C [34]. The mean duration of fever was 4.8 days in
these patients, which was similar to that of our patients
(4.63 days). Fever (100%) and other symptoms and signs,
reported by Hançerli et al. [35] among hospitalized chil-
dren in Istanbul included cough (82%), dyspnea (32%),
vomiting (27%), myalgia (19%), headache (18%), rhino-
rhea (15%), diarrhea (13%), and sore throat (8%).
The clinical characterization of AdV infection is desig-
nated by high grade (>39°C) and prolonged (up to 120
hours) fever [36]. Bezerra et al. reported that, AdV was
the second most common virus associated with RTI
hospitalization [8]. Similar to other studies, AdV wasalso commonly identified but not associated with severe
illness [8]. Hospitalized patients with AdV have symp-
toms of URTI (81.5%) and LRTI (18.5%). Fever (92.6%)
was the most commonly encountered symptom in hos-
pitalized children with AdV. The duration of fever in
this infection was more prolonged (up to 120 hours) in
our patients, compared to other viruses; this finding was
similar to other studies [36]. Dehydration (11.1%), febrile
convulsion (7.4%) and tachypnea (3.7%) were encoun-
tered rarely in these patients. Chen et al. reported that,
fever was recorded for 98.7% of patients with AdV, and
the mean level of fever was 39.2°C [37]. While the
mean duration of fever was 4.8 days in their patients,
our patients experienced a similar duration (4.63 days).
Other symptoms and signs include cough (77.6%), rales
(23.3%), diarrhea (25.2%), vomiting (21.8%), abdominal
pain (18.9%), conjunctivitis (13.6%), rashes (7.9%), and
febrile seizure (3.1%) as reported by Chen et al. [37].
The peak incidence of AdV occurred among children
2–5 years of age in our study, while Chen reported the
peak to occur between 4 and 8 years of age in Taiwan
[37]. Similar to our study, other studies reported that
most AdV infections occurred among children under 5
years of age [36,38]. Children hospitalized with AdV
were less likely to have LRTI, and were older than
patients with other viruses. The mortality rates were
reported in patients with AdV in Korean (19%) [38]
and Argentinean (28.6%) [39] children. There was no
mortality in patients with AdV, similar to the Chen re-
port [38]. Our patients with AdV mostly had URTI,
such as tonsillitis and pharyngitis (81.5%), with a few
patients with LRTI (18.5%). In a national report pre-
pared for 2006–2007, AdV was detected in 5.6% of
children hospitalized with acute LRTI, but, clinical
characteristics were not investigated [10]. Similar to
the rate reported in this study viruses were detected in
LRTI, but not URTI. AdV was shown in LRTI in our
study group in 4.8% of patients. Furthermore, AdV was
identified during February through July with peaks in
April and June. AdV was detected with other viruses in
33% of coinfected patients, especially with RhV.
Viral infections are known to cause hematologic com-
plications particularly cytopenies. Leukocytosis may also
occur in viral infections, as well as bacterial infections.
Lymphopenia was the most common form of cytopenia
that was seen in viral infections, particularly with FluA&B
[40,41]. Lymphopenia was the most notable finding in our
cases with FluA&B in children two years or older. The
main hematologic manifestation of influenza is lympho-
penia with decreased lymphocyte/neutrophil ratio. Leuko-
cytosis and neutrophilia were detected in the patients with
AdV and RhV. Monocytosis was the most significant find-
ing in the patients with AdV. There was not any negative
effect on the hematologic conditions of coinfections.
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The importance of respiratory viruses as the etiologic
agent of RTIs in hospitalized children was verified in
our study. Furthermore, RSV, AdV, PIV and RhV were
detected in over two-thirds of hospitalized patients with
RTI. RSV was found to account for half of LRTI hospitali-
zations. PIV, MPV and RhV were associated with LRTI.
Our study summarizes the clinical characteristics of viral
agents that were detected in children with RTI. The sever-
ity of diseases caused by RSV and RhV were higher than
other viruses. In AdV and FluA&B infections, fever lasted
longer than in other viruses. Coinfections were detected in
21% of the patients, especially with some pathogens, such
as RhV and MPV, whereas, AdV and RSV were more
commonly identified as single infections. The presence of
coinfections was not associated with increased disease se-
verity. RSV, Flu A&B, AdV, CoV and MPV exhibited
strong seasonal patterns, with Flu A&B and MPV cases
peaking over the rainy season (January-May and March-
May, respectively), and AdV peaking soon afterwards
(April-July). RhV and PIV were endemic throughout the
year, although RhV activity did appear to decrease between
December-March and RSV activity did appear to decrease
after May. Different PIVs circulated at different times of
the studied year.
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